Carter's (CRI) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $32.28 -3.79%
EPS Growth %: +20.3%
Financial Fact:
Royalty income: -10.67M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +20.3%
Financial Fact:
Royalty income: -10.67M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Carter's (NYSE: CRI) reported Q2 EPS of $0.79, $0.09 better than the analyst estimate of $0.70. Revenue for the quarter came in at $692.1 million versus the consensus estimate of $681.15 million.
Company reaffirms full year fiscal 2017 outlook: net sales growth of 4% to 6%; adjusted diluted EPS growth of 8% to 10%
For earnings history and earnings-related data on Carter's (CRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Carter's (CRI) at Outperform
- Activist investor presses Xerox to review financial services arm - Bloomberg
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
